ATACOR MEDICAL CLOSES $28M SERIES C FINANCING TO DELIVER NEXT GENERATION EV-ICD AND PACING OPTIONS FOR CARDIAC RHYTHM MANAGEMENT
FUNDING SUPPORTS REGULATORY SUBMISSIONS AND CLINICAL MILESTONES
ATACOR MEDICAL TO PRESENT ACUTE AND 3 MONTH RESULTS
FROM EXTRAVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (EV-ICD) STUDIES
ATACOR MEDICAL TO PRESENT PRELIMINARY RESULTS
FROM FIRST-IN-HUMAN EXTRAVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (EV-ICD) STUDY
ATACOR MEDICAL RECOGNIZED AS
FINALIST IN 2021 OCTANE HIGH TECH AWARDS
ATACOR MEDICAL TAKES HOME
2021 OCTANE HIGH TECH AWARD
ATACOR MEDICAL RELEASES NEW DATA DURING
THE HEART RHYTHM SOCIETY 2020 SCIENTIFIC SESSIONS
ATACOR MEDICAL RAISES $25M
TO CONTINUE EXTRACARDIAC PACING DEVELOPMENT
RESULTS SUPPORT FEASIBILITY OF
ENTIRELY EXTRACARDIAC, MINIMALLY INVASIVE, TEMPORARY PACING SYSTEM
ATACOR MEDICAL RAISES $8.8M
TO DEVELOP SUBSTERNAL CARDIAC PACING SYSTEM